Stock News

[$$] Eli Lilly’s Sarcoma Drug Combo Proves Ineffective in Trials
Eli Lilly Slides as Sarcoma Treatment Fails in Phase 3 Trial
Eli Lilly News: LLY Stock Falls on Sarcoma Study Failure
Lilly cancer drug fails key trial, will no longer be prescribed
Dow jumps 160 points as stock market set to end week with solid gains on China-trade optimism
Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®
Citron Says Ligand Has 80% Downside in Explosive Note

As seen on...